Medistim’s First Sale of VeriQC™ in the US

Medistim has signed contracts with three hospitals in the US and achieved its first revenues from the company’s new product VeriQC.

All three hospitals have entered into a lease agreement where they pay per usage. A procedure with VeriQC is priced at about twice the level of a procedure performed using the traditional equipment VeriQ™. The company expects that existing and new customers gradually will convert to VeriQC. 

Read more